JCJelmer Coenradij

Jelmer Coenradij

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Jelmer Coenradij has a total of 22 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Single-protein diffusion in micrometer-size vesicles is governed by viscosity, surface charge, and membrane interactions

    by Jelmer Coenradij, Dmitrii Linnik, Kristine Postmus, Zeynap Şensan, Matilde Accorsi, Christiaan M. Punter, Rumiana Dimova, Bert Poolman

    Giant unilamellar vesicles (GUVs) are a powerful model system for studying protein dynamics in cell-sized compartments with a precisely tunable physicochemical environment. Here, we apply Single-Molecule Displacement Mapping (SMdM) to quantify how luminal viscosity, ionic strength, membrane lipid composition, and protein surface charge of soluble proteins govern intraluminal single-molecule diffusion. Increasing viscosity led to a predictable decrease in the diffusion coefficient. However, spatially resolved diffusion measurements reveal reduced protein mobility near the membrane, suggesting additional membrane-proximal interactions not captured by particle-based simulations. We observe long-range (∼1 µm) effects of membrane charge on protein mobility that extend well beyond classical Debye screening, which may reflect shape fluctuations of the GUV membrane. For the membrane-associated protein LactC2, we resolve two distinct diffusing populations within a single vesicle, corresponding to free and membrane-bound states. Our workflow provides a quantitative framework for probing single-protein mobility in vesicle-based synthetic cells. These results advance our understanding of how molecular crowding and transient membrane interactions shape protein diffusion within cell-sized compartments, with possible implications for metabolic organization.

  • Open Access

    Accessible Gibbs energy at metabolic activation limits long-term cell growth

    by Yan B. Barreto, Elwin P. H. Jongman, Miyer F. Patiño-Ruiz, Douwe A. J. Grundel, Melike Uysal, Jelmer Coenradij, Bert Poolman, Matthias Heinemann

    When exposed to a nutrient, cells activate metabolism by reorganizing metabolite pools and enzyme expression to approach the maximal growth rate permitted by physicochemical constraints. While these constraints define reachable steady states, here we propose that the Gibbs energy accessible at activation further limits which states are reached. Using minimal metabolic models, we find that limited accessible Gibbs energy can trap cells in low-growth states by constraining metabolic reorganization and imposing a proteomic burden on transport and phosphorylation reactions. To investigate this experimentally, we reconstituted the arginine deiminase pathway in vesicles, revealing that the size of a conserved pool of interconverting metabolites (arginine, citrulline, and ornithine) determines accessible Gibbs energy and constrains steady-state ATP production rate, a proxy for growth. Together, these results indicate that cellular metabolism retains memory of its initial energetic state, with accessible Gibbs energy at activation acting as a thermodynamic constraint on long-term growth.

  • Open Access

    A SynBio community comes of age: Political, academical, industrial, and societal developments in the Netherlands

    by Darshak K. Bhatt, Marjolein E. Crooijmans, Jelmer Coenradij, Alicia Maciá Valero, Maarten Lubbers, Enrique Asin-Garcia, N. Amy Yewdall, Sarah D'ADamo, Nico J. Claassens, Sonja Billerbeck

    Synthetic biology (SynBio) is a rapidly growing scientific discipline. In the Netherlands, various universities and companies are tackling a variety of opportunities and challenges within this field. In this perspective article, we review the current synthetic biology landscape in the Netherlands across academia, industry, politics, and society. Especially within Dutch academia there is an active, though only partially connected, research community involved in various domains of SynBio. Mostly supported by governmental funding, academic research is focusing on top-down synthetic biology, involving the engineering of, for example, bacteria and yeast for bioproduction, as well as bottom-up and cell-free synthetic biology aiming to understand life and build synthetic cells. There is also a large number of talented and motivated students interested in the field, exemplified by the participation and success of Dutch teams in the international iGEM synthetic biology competition. Commercial synthetic biology activities are taking place in various large industrial companies, as well as in start-ups and spin-offs, mostly divided over several ‘SynBio hubs’ in the Netherlands. However, the investment, regulatory and public-perception landscape is not yet optimal to stimulate entrepreneurial activities in SynBio. The Dutch and global society can further benefit from the large promise of SynBio through better integration of people active in the Dutch SynBio field, frequent political and public dialogue, and more attention towards regulatory issues. The recently founded Dutch synthetic biology association SynBioNL aims to contribute to realizing a positive impact on society by stimulating advances of the field in the Netherlands and beyond.